Development of a DUX4-targeting antibody oligonucleotide conjugate as a therapy for FSHD.

Saved in:
Bibliographic Details
Title: Development of a DUX4-targeting antibody oligonucleotide conjugate as a therapy for FSHD.
Authors: Malecova B; Avidity Biosciences, Inc., 3020 Callan Rd, San Diego, CA 92121, USA., Sala D; Avidity Biosciences, Inc., 3020 Callan Rd, San Diego, CA 92121, USA., Melikian GM; Avidity Biosciences, Inc., 3020 Callan Rd, San Diego, CA 92121, USA., Johns R; Avidity Biosciences, Inc., 3020 Callan Rd, San Diego, CA 92121, USA., Erdogan G; Avidity Biosciences, Inc., 3020 Callan Rd, San Diego, CA 92121, USA., Hartmann M; Avidity Biosciences, Inc., 3020 Callan Rd, San Diego, CA 92121, USA., Jordan M; Avidity Biosciences, Inc., 3020 Callan Rd, San Diego, CA 92121, USA., Arias JD; Avidity Biosciences, Inc., 3020 Callan Rd, San Diego, CA 92121, USA., Bhattacharya A; Avidity Biosciences, Inc., 3020 Callan Rd, San Diego, CA 92121, USA., Meng Q; Avidity Biosciences, Inc., 3020 Callan Rd, San Diego, CA 92121, USA., Dansereau O; Avidity Biosciences, Inc., 3020 Callan Rd, San Diego, CA 92121, USA., Beppler SW; Avidity Biosciences, Inc., 3020 Callan Rd, San Diego, CA 92121, USA., Doppalapudi VR; Avidity Biosciences, Inc., 3020 Callan Rd, San Diego, CA 92121, USA., Huang H; Avidity Biosciences, Inc., 3020 Callan Rd, San Diego, CA 92121, USA., Flanagan WM; Avidity Biosciences, Inc., 3020 Callan Rd, San Diego, CA 92121, USA., Levin AA; Avidity Biosciences, Inc., 3020 Callan Rd, San Diego, CA 92121, USA.
Source: Nucleic acids research [Nucleic Acids Res] 2026 Apr 13; Vol. 54 (7).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0411011 Publication Model: Print Cited Medium: Internet ISSN: 1362-4962 (Electronic) Linking ISSN: 03051048 NLM ISO Abbreviation: Nucleic Acids Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1362-4962
DOI:10.1093/nar/gkag301